CBDNewsBreaks – EVIO, Inc. (EVIO) Obtains Expanded Accreditation to Conduct Pesticide, Residual Solvent Tests

Company: EVIO, Inc. (EVIO)
Category: News

EVIO, Inc. (OTCQB: EVIO), a national leader in providing accredited analytical testing, scientific research and advisory services to the regulated cannabis industry, today announced that it has been granted an expansion to its accreditations from the Oregon Environmental Laboratory Accreditation Program (“ORELAP”), a division of the Oregon Health Authority. The newly expanded accreditations enable EVIO Labs to offer full-scope pesticide testing at its Medford location. Additionally, EVIO received accreditation to test for residual solvent residues at its Portland location. “Bringing pesticide testing fully in-house and expanding our capability with residual solvent analysis will also allow us to substantially increase our market opportunity and simultaneously become an even more formidable competitor statewide,” EVIO CEO William Waldrop stated in the news release.

To view the full press release, visit http://cnw.fm/v1LJB

About EVIO, Inc.

EVIO, Inc. is an Oregon-based life sciences company that provides analytical testing services, management advisory services and scientific research to the legal cannabis and hemp industries. The company’s EVIO Labs division operates state-of-the-art facilities and offers accredited testing methodologies to ensure the safety and quality of the nation’s cannabis supply. For more information, visit the company’s website at www.EvioLabs.com.

More from CannabisNewsBreaks

About CBDWire

CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
[email protected]

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000